Clinical Trials
LACOG 0215 - EVA 001
Title
Prospective evaluation of patients with uterine cervical cancer in Brazilian health institutions - The EVITA I study
Primary Objective
Characterization of uterine cervical cancer in the Brazilian population
Design
All patients diagnosed with CC in 1-year period (IIB to IIA high risk or IIB-IVB or recurrent disease) at the participating sites will be included. Data will be collected in LACOG selected sites (N=14).
Sample size: 800
Sponsor: Roche
Status: Recruiting.
Scientific comittee: Angélica Nogueira-Rodrigues, Andréia Cristina de Melo, Aknar Freire de Carvalho Calabrich, Fernando Cotait Maluf, Gustavo Werustky
Registry
Clinicaltrials.gov: NCT02671071
Contact
lacog@lacog.org.br
Phone: 55 51 3384 5334